Please login to the form below

Not currently logged in
Email:
Password:

Allergan opens Indian pharma R&D arm

US-headquartered Allergan has opened its first pharmaceutical R&D facility in India

According to local media reports, US-headquartered Allergan has opened its first pharmaceutical R&D facility in India.

The Allergan Pharmaceutical Development Centre India, which will make up part of Allergan's worldwide R&D operations, will focus on implementing global pharmaceutical R&D projects conducted in the region.

According to Scott M Whitcup, Allergan's worldwide executive vice-president of R&D, the centre would have 15 clinical research and data management personnel at the start of operations and could double within two years.

Whitcup said that Allergan's estimated investment for the new centre at USD 3m to USD 5m over the next few years. He added that R&D activities at the centre would initially focus on therapies in areas such as inflammatory and infective conditions of the eye, movement disorders and urological indications.

The centre is Allergan's third largest outside of the US. The company also has Allergan India, which manages the commercial side of Allergan's business there.

8th August 2007

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....